3-(5-methyl-4-(4-sulfamoylphenyl)isoxazol-3-yl)benzenesulfonamide

Catalog No. :
ACOTSD007
CAS No. :
1373038-59-5
Molecular Formula :
C16H15N3O5S2
Molecular Weight :
393.45

IUPAC Name:3-(5-methyl-4-(4-sulfamoylphenyl)isoxazol-3-yl)benzenesulfonamide

3-(5-methyl-4-(4-sulfamoylphenyl)isoxazol-3-yl)benzenesulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(5-methyl-4-(4-sulfamoylphenyl)isoxazol-3-yl)benzenesulfonamide
IUPAC Name3-(5-methyl-4-(4-sulfamoylphenyl)isoxazol-3-yl)benzenesulfonamide
Molecular FormulaC16H15N3O5S2
Molecular Weight393.45
SMILESCC1=C(C2=CC=C(S(N)(=O)=O)C=C2)C(C2=CC(S(N)(=O)=O)=CC=C2)=NO1
InChI KeyZTJZYTUGYRMBJV-UHFFFAOYSA-N
SynonymBenzenesulfonaMide, 3-[4-[4-(aMinosulfonyl)phenyl]-5-Methyl-3-isoxazolyl]-;3-[4-[4-(Aminosulfonyl)phenyl]-5-methyl-3-isoxazolyl]benzenesulfonamide;3-[5-Methyl-4-(4-sulfamoylphenyl)-1,2-oxazol-3-yl]benzenesulfonamide;Parecoxib SodiuM iMpurity PR-12-E;Parecoxib-007;3,3'-(5-methylisoxazole-3,4-diyl)dibenzenesulfonamide;Parecoxib Impurity 34;Parecoxib impurity 8/3-(5-Methyl-4-(4-sulfamoylphenyl)isoxazol-3-yl)benzenesulfonamide
CAS No.1373038-59-5

Synthetic Route by SureRoute

1. ACOTSD007 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKMRC630 route compound structure diagram
    ACKMRC630613660-87-0 In Stock
  4. Then
  5. ACOTSD007 route product structure diagram
    ACOTSD0071373038-59-5
Inquiry

2. ACOTSD007 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACXEPD093 route compound structure diagram
    ACXEPD093701-34-8 In Stock
  4. Then
  5. ACOTSD007 route product structure diagram
    ACOTSD0071373038-59-5
Inquiry

Comments (0)